A new estrogen receptor agonist is being evaluated for the treatment of postmenopausal symptoms. A prospective study shows that the drug increases the risk of deep vein thrombosis (DVT) in treated women who smoke compared to untreated women who smoke, with a relative risk (RR) of 1.70 and p-value of 0.01. In nonsmokers, no increased risk of DVT is evident with use of the drug (RR = 0.96; p-value = 0.68) . Which of the following describes this phenomenon?
A) Confounding
B) Effect modification
C) Latent period
D) Observer bias
E) Selection bias
Correct Answer:
Verified
Q9: A 65-year-old man with a history of
Q10: A surveillance study is conducted to assess
Q11: A large prospective study evaluates the relationship
Q12: A geneticist is interested in the potential
Q13: A group of researchers conduct a study
Q15: An epidemiologist wants to conduct a study
Q16: Researchers conduct a prospective study that demonstrates
Q17: Pulmonary capillary wedge pressure (PCWP) measurements can
Q18: A new biomarker has been shown to
Q19: A hospital wants to estimate the prevalence
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents